Need professional-grade analysis? Visit stockanalysis.com
$1.46B
N/A
74
N/A
Mind Medicine Inc (MNMD) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $15.38, up 2.40% from the previous close.
Over the past year, MNMD has traded between a low of $5.80 and a high of $15.38. The stock has gained 165.2% over this period. It is currently 165.2% above its 52-week low.
Mind Medicine Inc has a market capitalization of $1.46B.
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Side-by-side comparison against top Healthcare peers.